Leadership and Strategy in Pharmaceuticals and Biotech

Thank you for your interest in Executive Education at Harvard Business School. The Leadership and Strategy in Pharmaceuticals and Biotech program will not be offered in 2013. Additional information is not available at this time.

For a complete list of the most current HBS Executive Education programs, please bookmark the program finder.

You also may contact our client service specialists at 1-800-427-5577 (outside the U.S., dial +1-617-495-6555) or at executive_education@hbs.edu.

Revolutions in technology, markets, and government policy are transforming the playing field for pharmaceutical and biotechnology companies. This program prepares high-potential executives to become better managers and leaders—and lays a foundation for strategically positioning their companies for a world of change.

What You Can Expect
Created to enhance individual leadership capacity and boost corporate performance, this leadership development program enables participants to evaluate alternative business models, competitive strategies, and financial approaches, as well as explore issues ranging from profitability, organizational change, and intellectual property to global distribution.

Your Course of Study
Case studies, lectures, and panel sessions explore the industry's defining issues. The intensive curriculum examines areas such as R&D and product lifecycle management, which present formidable management challenges requiring expert leadership.

Who Is Right for the Program
The program is designed for senior executives and small teams responsible for process research and development, research and discovery, clinical development, regulatory affairs, product development, manufacturing, operations, marketing, business development, and finance.

What You Can Expect

Improving Your Organization's Performance

For pharmaceutical or biotech companies, today's marketplace is characterized by seemingly constant change. Ongoing developments in technology, mergers and acquisitions, and government regulations require corporate leaders to assess alternative business and financial strategies.

This program addresses the challenges that industry executives face as they compete in a global environment. Featuring case studies, lectures, and discussions, it explores essential issues that include intellectual property rights, market positioning, risk management, and more.

Taking Your Skills to the Next Level

Interacting with faculty experts and influential peers, you will learn to:

  • Analyze the rapidly changing and complex political landscape affecting intellectual property
  • Examine issues surrounding the global pricing and distribution of pharmaceuticals
  • Evaluate alternative business models, competitive strategies, and financial approaches
  • Identify effective ways to develop, manufacture, and market innovative products

Your Course of Study

The curriculum examines critical areas that hold serious implications for pharmaceutical and biotech companies today. Key topics include:

  • The unique concerns of dealing with research in a global environment: organizing for the most effective results and encouraging technological innovation, while effectively licensing and preserving intellectual property for a competitive edge
  • The impact of business models and alliances, especially given the slew of mergers and acquisitions that are reshaping the industry
  • Staying competitive in a quickly shifting industry, including managing product life cycles and determining market positioning and pricing
  • Developing appropriate financial strategies and control systems that incorporate risk management
  • Creating sustainable leadership within the organization to encourage managerial stability

"This program forces you to examine the orthodoxies held by the industry and yourself. The case discussion on developing world access to medicines not only turned my thinking 180 degrees, but also enabled me to directly apply our work on establishing control boundaries to the integration of an acquisition."
Brian E. Edelman [Director, Corporate Strategic Planning], Eli Lilly and Company, U.S.

Who Is Right for the Program

This program is designed for leaders in both pharmaceutical and emerging biotechnology companies. It will be highly beneficial to those responsible for research and discovery, process research and development, clinical development, regulatory affairs, product development, manufacturing, operations, marketing, business development, and finance. Whenever possible, we encourage companies to send up to three individuals, thereby extending the learning through several functional areas.

Past Participants Represented:

<>
 
Sales Volume Nationalities
7% Less than $29.9 million 12% Asia/Pacific
6% $30-99.99 million 28% Europe
5% $100-499.99 million 6% Latin America
7% $500-999.99 million 54% North America
15% $1-2.49 billion
9% $2.5-4.99 billion
8% $5-9.99 billion
43% $10+ billion

Participating Companies Have Included:

Allergan, Inc.
Amgen, Inc.
Aventis
Battelle Memorial Institute
Bayer AG
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Dendrite International, Inc.
DFB Pharmaceuticals, Inc.
Diffusion Pharmaceuticals LLC
Eli Lilly and Company
Genzyme Corporation

ICOS Corporation
Johnson & Johnson
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Nektar Therapeutics
Nestlé S.A.
Novartis AG
Novo Nordisk A/S
Pfizer, Inc.
Schering AG
Sereno S.A.

Meet the Program Faculty

Harvard Business School Executive Education programs are developed and taught by a core faculty of HBS professors who are skilled educators, groundbreaking researchers, and award-winning authors. Faculty leverage their business expertise and field-based research to create new knowledge and enduring concepts that shape the practice of management. The result is a teaching team that exposes participants to multiple perspectives, challenging their thinking on many levels. For more detailed biographies, click on each faculty name.

Arthur A. Daemmrich, Assistant Professor of Business Administration. Member of the Business, Government and the International Economy Unit; and member of the Healthcare Initiative.

Gary P. Pisano, Harry E. Figgie, Jr. Professor of Business Administration. Member of the Technology and Operations Management Unit; member of the Healthcare Initiative, and the Science-Based Business Initiative.

Vicki L. Sato, Professor of Management Practice, Harvard Business School. Professor of the Practice in the Department of Molecular and Cell Biology, Harvard University. Member of the Technology and Operations Management Unit.

Michael L. Tushman, Paul R. Lawrence MBA Class of 1942 Professor of Business Administration. Member of the Organizational Behavior Unit; and faculty cochair of "Leading Change and Organizational Renewal."

Admissions

Because a diverse participant mix is an important part of every HBS Executive Education program, we look for candidates who reflect a broad range of industries, functions, countries, and backgrounds to enrich the learning experience.

Fees, Payments, and Cancellations

The program fee covers tuition, books, case materials, accommodations, and most meals.

No payment is necessary until you have been accepted into an HBS Executive Education program. After admission notification, we will send you an invoice via email; payment is due within 30 days of the invoice date. If admission is within 30 days prior to the start of the program, payment is due upon receipt of the invoice. Payment is required prior to the program start date. We accept payment by company check, bank wire transfer, or credit card (American Express, MasterCard, Visa). Details are included on the program invoice.

If you need to cancel or defer participation, you must submit your request in writing more than 30 days before the start of the program to receive a full refund. Due to program demand and the volume of preprogram preparation, cancellations or deferrals received 14 to 30 days prior to the start of the program are subject to a fee of one-half of the program fee. Requests received within 14 days are subject to full payment.

Requirements

Although there are no formal educational requirements, admission is a selective process based on professional achievement and organizational responsibility. We look for professionals who have demonstrated business talent and leadership potential.

HBS Executive Education programs enrich both participants and their sponsoring organizations, and require full commitment from each party. While participants devote time and intellect to the learning experience, sponsoring organizations agree to relieve individuals of their work responsibilities during the program.

Language Proficiency

We deliberately design our programs to encourage individual growth and to foster productive interaction among participants. For that reason, proficiency in written and spoken English is essential. If English is your second language, or if you have less than one year's experience working in an English-speaking environment, HBS requires a brief statement documenting proficiency in English-language skills, both conversational and written. This may include a list of the English-language certification programs that you have completed; the degrees you have earned at English-speaking colleges and universities; or the results of the Test of English as a Foreign Language (TOEFL) exam. The Admissions Committee also may request a telephone interview.

Application Process

Program participants must be nominated and sponsored by their current employer. HBS must receive your application and all required documents in order to prepare the application for review by the Admissions Committee.

To apply, you may use our online form or download an application. You also may request a brochure by mail.

If you submit your application online, we will promptly acknowledge receipt of your submission via email. In the unlikely event that an email acknowledgment is not received, please contact the Admissions Committee by email: exed_admissions@hbs.edu, phone: +1-617-495-6226, or fax: +1-617-496-1731.

If you choose to submit a printed application, be sure to type or print legibly and sign your application. Send the application to the address or fax number listed on the form. Mailed or faxed applications are processed and acknowledged promptly upon receipt via email.

Complete Your Application

Please answer all questions thoroughly—the Admissions Committee will only consider completed applications. After reviewing your application and making the necessary edits or corrections, print or copy the application for your records.

Meet the Deadlines

We request applications at least four weeks in advance of the program start date. Early application does not guarantee admission. Programs often fill to capacity, so early application is recommended.

Notification of Acceptance

We acknowledge receipt of all applications and maintain all application information in strict confidentiality.

To optimize the learning experience and maximize the exchange of ideas, the Admissions Committee selects a class that balances each participant's experience, the scope of his or her current responsibilities, and the type of organization.

The Admissions Committee begins reviewing applications four months before the start date, and qualified candidates are admitted on a rolling, space-available basis. Once the review process has begun, applicants are notified within three weeks via email regarding Admissions Committee decisions. If your application is received within three weeks of the program's start date, the Admissions Committee will notify you of their decision as soon as possible.

Need help?

For further assistance, contact our client service specialists at: 1-800-427-5577 (outside the U.S., dial +1-617-495-6555).